These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 25308364

  • 1. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
    Wei W, Sun HH, Li N, Li HY, Li X, Li Q, Shen XH.
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):529-38. PubMed ID: 25308364
    [Abstract] [Full Text] [Related]

  • 2. BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling.
    Liu X, Tian X, Wang F, Ma Y, Kornmann M, Yang Y.
    Eur J Cancer; 2014 Sep; 50(13):2251-62. PubMed ID: 24953335
    [Abstract] [Full Text] [Related]

  • 3. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma.
    Song Y, Zou L, Li J, Shen ZP, Cai YL, Wu XD.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8161-8168. PubMed ID: 30556854
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of ribosomal associated protein hnRNP D in gemcitabine-resistant pancreatic cancer.
    Wang C, Huang H.
    Biochem Biophys Res Commun; 2021 Nov 19; 579():181-187. PubMed ID: 34624736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
    Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, Zhu M.
    BMC Cancer; 2013 Oct 25; 13():496. PubMed ID: 24156409
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H, Gao W, Li X, Yu L, Luo D, Liu Y, Yu X.
    Pancreatology; 2021 Apr 25; 21(3):589-598. PubMed ID: 33579599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J, Liu S, Yang X, Cao S, Zhou Y.
    Life Sci; 2020 Dec 15; 263():118523. PubMed ID: 33039386
    [Abstract] [Full Text] [Related]

  • 13. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
    Griesmann H, Ripka S, Pralle M, Ellenrieder V, Baumgart S, Buchholz M, Pilarsky C, Aust D, Gress TM, Michl P.
    Neoplasia; 2013 Jan 15; 15(1):11-22. PubMed ID: 23359789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.
    Ng SSW, Tsao MS, Chow S, Hedley DW.
    Cancer Res; 2000 Oct 01; 60(19):5451-5. PubMed ID: 11034087
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.
    Biliran H, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD.
    Clin Cancer Res; 2005 Aug 15; 11(16):6075-86. PubMed ID: 16115953
    [Abstract] [Full Text] [Related]

  • 17. Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance.
    Wang X, Su W, Qin C, Gao R, Shao S, Xu X, Zhang Z, Gao J.
    Front Biosci (Landmark Ed); 2024 Jul 25; 29(7):269. PubMed ID: 39082329
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE.
    Cancer Res; 2004 Jun 01; 64(11):3987-93. PubMed ID: 15173012
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE.
    Clin Cancer Res; 2004 Apr 01; 10(7):2307-18. PubMed ID: 15073106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.